Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics

Less than half of severe asthmatic patients show a >80% adherence rate to inhaled treatment just before and during biologic therapy. This has implications in biologic treatment sustainability and disease prevalence estimation. http://bit.ly/3cRTJB0

Detalles Bibliográficos
Autores principales: Caminati, Marco, Vianello, Andrea, Andretta, Margherita, Menti, Anna Michela, Tognella, Silvia, Degli Esposti, Luca, Micheletto, Claudio, Bovo, Chiara, Senna, Gianenrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184111/
https://www.ncbi.nlm.nih.gov/pubmed/32363204
http://dx.doi.org/10.1183/23120541.00017-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184111/
https://www.ncbi.nlm.nih.gov/pubmed/32363204
http://dx.doi.org/10.1183/23120541.00017-2020

Ejemplares similares